NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.

Translated title of the contribution: NOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.

H.M van der Straaten, M.M. Paquay, M.G.J. Tilanus, N. van Geloven, L.F. Verdonck, C. Huisman

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNOD2/CARD15 variants are not a risk factor for clinical outcome after nonmyeloablative allogeneic stem cell transplantation.
Original languageUndefined/Unknown
Pages (from-to)1231-1236
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume17
Issue number8
Publication statusPublished - 2011

Cite this